Skip to main content

Currently Skimming:

Promoting the Scientific Basis for the Regulation of Drugs
Pages 2-3

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 2...
... The third FDA Commissioner Peggy Hamburg focused on advances in post-market drug safety since the passage of FDAAA. A fourth meeting, to be held in 2010, will focus on the science infrastructure at FDA and the estab lishment of centers of excellence to advance regulatory science.
From page 3...
... Proceedings are not published, but presen tations are available on the Forum website. FDA Community Update: Personalized Medicine and the Genetic Basis of Adverse Events Following the publication of the IOM report on the FDA, The Future of Drug Safety: Promoting and Protecting the Health of the Public, and the passage of the FDA Amendments Act of 2007, the Forum initiated the FDA Community Update discussion series to keep the Washington policy community apprised of the agency's progress on implementing its safety initiatives.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.